Our results show that the PD + Omaveloxolone group had significantly higher TH expression in the substantia nigra area than the PD group (Figure 9C, 91.51–101.83 vs. 52.60–70.06, P = 0.0003), representing a significant reduction in the loss of dopaminergic neurons. This evidence concerns the gene TH and Parkinson disease.